Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 10, 2009Molecular TherapyOpen Access

Proteasome Inhibitors Decrease AAV2 Capsid derived Peptide Epitope Presentation on MHC Class I Following Transduction

View Full Paper
Ask AI
Bookmark
Share

Authors

JFJonathan D. FinnDHDaniel J. HuiHDHarre D. Downey

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Finn et al. (2009) studied this question.

synapsesocial.com/papers/6a8aa313af65c378f7fd50cahttps://doi.org/10.1038/mt.2009.257
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Successful expression of human factor IX following repeat administration of adenoviral vector in mice.1996 · 127 citations
  2. 2Immune Responses to AAV in Clinical Trials2011 · 318 citations
  3. 3The Proteasome and Its Inhibitors in Immune Regulation and Immune Disorders2006 · 28 citations
  4. 4Proteasome Inhibitor PS-341 Induces Apoptosis through Induction of Endoplasmic Reticulum Stress-Reactive Oxygen Species in Head and Neck Squamous Cell Carcinoma Cells2004 · 429 citations
  5. 5Reactive Oxygen Species Generation and Mitochondrial Dysfunction in the Apoptotic Response to Bortezomib, a Novel Proteasome Inhibitor, in Human H460 Non-small Cell Lung Cancer Cells2003 · 462 citations